← Back to Screener
Psyence Biomedical Ltd. Warrant (PBMWW)
Price$0.03
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)-31.63%
Price vs S&P 500 (4W)-9.38%
VGM Score93.63
All Metrics
Price vs S&P 500 (YTD)28.85%
10-Day Avg Trading Volume0.05M
3-Month Avg Trading Volume0.06M
52-Week High$0.09
26-Week Price Return-23.71%
13-Week Price Return30.05%
3-Month Return Std Dev284.39%
Year-to-Date Return34.95%
5-Day Price Return-23.94%
Month-to-Date Return-16.61%
Price vs S&P 500 (13W)21.80%
Beta-0.07x
52-Week Low$0.01
mGradeA
vgmGradeA
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PBMWWPsyence Biomedical Ltd. Warrant | — | — | A | $0.03 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Psyence Biomedical develops natural psilocybin products for treating psychological trauma and mental health conditions in palliative care, currently advancing candidates through clinical trials. The company operates a federally licensed cultivation facility in Southern Africa, producing and exporting psilocybin for standardized pharmaceutical processing by international partners. This positions the company at the intersection of emerging psychedelic therapeutics and regulated mental health treatment markets.